drugset / Trial / NCT01859949

Long Term Study of Genotropin (Somatropin) for Short Children Born Small for Gestational Age (SGA)

NCT01859949

Phase 4 Completed 62 enrolled Pfizer
NaSingle-groupOpen-labelTreatment

Summary

To assess the long-term safety of Genotropin(somatropin) on Small for Gestational Age (SGA) without epiphyseal closing.

Timeline

Start
2002-10
Primary completion
2015-08
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatropin Protein / enzyme biologic 0.033 mg/kg
Subject Somatropin Protein / enzyme biologic 0.067 mg/kg